Stocks to Watch: Netapp, Myriad Genetics, Boston Scientific and More...

Six in 60
Six in 60

Stocks shaved some of their earlier losses Wednesday, but were still under pressure following a handful of weaker-than-expected economic news and amid worries over renewed concerns over the Greek debt situation.

The Dow Jones Industrial Average pared some of its earlier losses to flirt with the psychologically-important 12,000 mark, after posting its biggest gain in almost two monthsduring the previous session.

Here are six stocks that are on the move:

The computer hardware company was upgraded to outperform from neutral at Credit Suisse while raising the price target to $62 from $54.


The glass container manufacturer cut its second quarter profit outlook blaming weak demand in Asia and supply chain problems in North America.


Diamond Foods
The packaged food company was initiated a buy at Jefferies with an $80 price target.


Myriad Genetics
The biotech company was downgraded to hold from buy at Auriga.


General Dynamics
The defense company was initiated a buy at Lazard Capital with an $86 price target.


Boston Scientific
The medical equipment manufacturer was up 3.7%...perhaps on hopes the Bruins will win the Stanley Cup in game seven in Vancouver.


Get the latest stock picks on the CNBC Stock Blog.